Research Project
Grant-in-Aid for Research Activity Start-up
Administration of incretin(human GLP-1 analog) or insulin signal peptide L7-24 with CFA improved diabetes in newly diabetic NOD mice. Administration of CFA with or without incretin delayed diabetes onset in diabetes-accelerating NY8. 3 NOD mice. These results suggested that immune tolerance in type 1 diabetes might be induced by incretin or insulin signal peptide L7-24 with CFA.
All 2012 2011 2010
All Journal Article (4 results) (of which Peer Reviewed: 4 results) Presentation (12 results)
Biochem Biophys Res Commun
Volume: 408(2) Pages: 306-11
Volume: 408 Issue: 2 Pages: 306-311
10.1016/j.bbrc.2011.04.026
Clin Immunol
Volume: 136(1) Pages: 74-82
Clinical Immunology
Volume: 136 Pages: 74-82